These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 8288954

  • 1. von Willebrand factor binding to collagen in patients with end-stage renal disease.
    Niesvizky R, Calandri C, Patel ND, Zhou SL, Potter BJ, Rand JH.
    J Lab Clin Med; 1994 Jan; 123(1):137-42. PubMed ID: 8288954
    [Abstract] [Full Text] [Related]

  • 2. Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2.
    Klemm T, Mehnert AK, Siegemund A, Wiesner TD, Gelbrich G, Blüher M, Paschke R.
    Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):568-72. PubMed ID: 16320153
    [Abstract] [Full Text] [Related]

  • 3. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
    Neugebauer BM, Goy C, Budek I, Seitz R.
    Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237
    [Abstract] [Full Text] [Related]

  • 4. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.
    Geisen U, Heilmann C, Beyersdorf F, Benk C, Berchtold-Herz M, Schlensak C, Budde U, Zieger B.
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712
    [Abstract] [Full Text] [Related]

  • 5. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL, Siekmann J, Schwarz HP.
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
    Vanhoorelbeke K, Cauwenberghs N, Vandecasteele G, Vauterin S, Deckmyn H.
    Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239
    [Abstract] [Full Text] [Related]

  • 10. [Von Willebrand factor in hemodialysed patients with chronic renal failure].
    Bronisz M, Rość D, Paczuski R, Nartowicz E, Bronisz A.
    Pol Merkur Lekarski; 2001 Jul; 11(61):40-3. PubMed ID: 11579829
    [Abstract] [Full Text] [Related]

  • 11. Von Willebrand factor (vWF) antigen levels and function in healthy Thais.
    Rojnuckarin P, Akkawat B, Intragumtornchai T.
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1292-7. PubMed ID: 16438160
    [Abstract] [Full Text] [Related]

  • 12. Effect of ABO blood group on the collagen-binding assay for von Willebrand factor.
    Haley E, Babar N, Ritter C, Downes KA, Green D, Shurin S, Sarode R.
    Am J Hematol; 2002 Nov; 71(3):229-31. PubMed ID: 12410584
    [Abstract] [Full Text] [Related]

  • 13. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C, Hilbert L, Vanhoorelbeke K, Deckmyn H, Goudemand J, Mazurier C.
    Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
    [Abstract] [Full Text] [Related]

  • 14. Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure.
    Holvoet P, Donck J, Landeloos M, Brouwers E, Luijtens K, Arnout J, Lesaffre E, Vanrenterghem Y, Collen D.
    Thromb Haemost; 1996 Nov; 76(5):663-9. PubMed ID: 8950769
    [Abstract] [Full Text] [Related]

  • 15. Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.
    Kirmizis D, Tsiandoulas A, Pangalou M, Koutoupa E, Rozi P, Protopappa M, Barboutis K.
    Med Sci Monit; 2006 Feb; 12(2):CR55-62. PubMed ID: 16449948
    [Abstract] [Full Text] [Related]

  • 16. [Application of collagen-binding assay for von Willebrand disease].
    Zhou J, Jia YQ, Jiang H, Yang YM, Deng CQ.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):126-9. PubMed ID: 14981837
    [Abstract] [Full Text] [Related]

  • 17. von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtype and mortality.
    Catto AJ, Carter AM, Barrett JH, Bamford J, Rice PJ, Grant PJ.
    Thromb Haemost; 1997 Jun; 77(6):1104-8. PubMed ID: 9241740
    [Abstract] [Full Text] [Related]

  • 18. A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor.
    Vanhoorelbeke K, Cauwenberghs N, Vauterin S, Schlammadinger A, Mazurier C, Deckmyn H.
    Thromb Haemost; 2000 Jan; 83(1):107-13. PubMed ID: 10669163
    [Abstract] [Full Text] [Related]

  • 19. Autoantibody to von Willebrand factor in systemic lupus erythematosus.
    Soff GA, Green D.
    J Lab Clin Med; 1993 Mar; 121(3):424-30. PubMed ID: 8445290
    [Abstract] [Full Text] [Related]

  • 20. Detection of von Willebrand disorder and identification of qualitative von Willebrand factor defects. Direct comparison of commercial ELISA-based von Willebrand factor activity options.
    Favaloro EJ.
    Am J Clin Pathol; 2000 Oct; 114(4):608-18. PubMed ID: 11026108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.